Patents by Inventor ANDREA VARSAVSKY

ANDREA VARSAVSKY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11406295
    Abstract: Methods and systems for sensor calibration and sensor glucose (SG) fusion are used advantageously to improve the accuracy and reliability of orthogonally redundant glucose sensor devices, which may include optical and electrochemical glucose sensors. Calibration for both sensors may be achieved via fixed-offset and/or dynamic regression methodologies, depending, e.g., on sensor stability and Isig-Ratio pair correlation. For SG fusion, respective integrity checks may be performed for SG values from the optical and electrochemical sensors, and the SG values calibrated if the integrity checks are passed. Integrity checks may include checking for sensitivity loss, noise, and drift. If the integrity checks are failed, in-line sensor mapping between the electrochemical and optical sensors may be performed prior to calibration.
    Type: Grant
    Filed: July 25, 2019
    Date of Patent: August 9, 2022
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Andrea Varsavsky, Xiaolong Li, Mike C. Liu, Yuxiang Zhong, Ning Yang
  • Patent number: 11382527
    Abstract: Electrochemical Impedance Spectroscopy (EIS) is used in conjunction with continuous glucose monitors and continuous glucose monitoring (CGM) to enable in-vivo sensor calibration, gross (sensor) failure analysis, and intelligent sensor diagnostics and fault detection. An equivalent circuit model is defined, and circuit elements are used to characterize sensor behavior.
    Type: Grant
    Filed: December 8, 2020
    Date of Patent: July 12, 2022
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Andrea Varsavsky, Fei Yu, Ning Yang
  • Patent number: 11382538
    Abstract: Methods and systems for sensor calibration and sensor glucose (SG) fusion are used advantageously to improve the accuracy and reliability of orthogonally redundant glucose sensor devices, which may include optical and electrochemical glucose sensors. Calibration for both sensors may be achieved via fixed-offset and/or dynamic regression methodologies, depending, e.g., on sensor stability and Isig-Ratio pair correlation. For SG fusion, respective integrity checks may be performed for SG values from the optical and electrochemical sensors, and the SG values calibrated if the integrity checks are passed. Integrity checks may include checking for sensitivity loss, noise, and drift. If the integrity checks are failed, in-line sensor mapping between the electrochemical and optical sensors may be performed prior to calibration.
    Type: Grant
    Filed: July 25, 2019
    Date of Patent: July 12, 2022
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Andrea Varsavsky, Xiaolong Li, Mike C. Liu, Yuxiang Zhong, Ning Yang
  • Publication number: 20220189630
    Abstract: Methods, systems, and devices for improving continuous glucose monitoring (“CGM”) are described herein. More particularly, the methods, systems, and devices describe retrieving a machine learning model that is trained to classify CGM sensor data and blanking the CGM sensor data based on an outlier classification from the machine learning model. The system may terminate sensors for which there is an aggregation of blanked CGM sensor data. The methods, systems, and devices described herein may additionally comprise a machine learning model that is trained to detect and correct for erroneous sensor use conditions based on error patterns in sensor data. The system may determine resolutions for correcting the detected erroneous sensor use conditions.
    Type: Application
    Filed: December 14, 2020
    Publication date: June 16, 2022
    Inventors: ELAINE GEE, JEFFREY NISHIDA, PETER AJEMBA, KEITH NOGUEIRA, ANDREA VARSAVSKY
  • Publication number: 20220189631
    Abstract: Methods, systems, and devices for improving continuous glucose monitoring (“CGM”) are described herein. More particularly, the methods, systems, and devices describe retrieving a machine learning model that is trained to classify CGM sensor data and blanking the CGM sensor data based on an outlier classification from the machine learning model. The system may terminate sensors for which there is an aggregation of blanked CGM sensor data. The methods, systems, and devices described herein may additionally comprise a machine learning model that is trained to detect and correct for erroneous sensor use conditions based on error patterns in sensor data. The system may determine resolutions for correcting the detected erroneous sensor use conditions.
    Type: Application
    Filed: January 29, 2021
    Publication date: June 16, 2022
    Inventors: ELAINE GEE, JEFFREY NISHIDA, PETER AJEMBA, KEITH NOGUEIRA, ANDREA VARSAVSKY
  • Patent number: 11344235
    Abstract: A continuous glucose monitoring system may utilize externally sourced information regarding the physiological state and ambient environment of its user for externally calibrating sensor glucose measurements. Externally sourced factory calibration information may be utilized, where the information is generated by comparing metrics obtained from the data used to generate the sensor's glucose sensing algorithm to similar data obtained from each batch of sensors to be used with the algorithm in the future. The output sensor glucose value of a glucose sensor may also be estimated by analytically optimizing input sensor signals to accurately correct for changes in sensitivity, run-in time, glucose current dips, and other variable sensor wear effects.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: May 31, 2022
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Keith Nogueira, Peter Ajemba, Michael E. Miller, Steven C. Jacks, Jeffrey Nishida, Andy Y. Tsai, Andrea Varsavsky
  • Publication number: 20220125352
    Abstract: A single, optimal, fused sensor glucose value may be calculated based on respective sensor glucose values of a plurality of redundant working electrodes (WEs) of a glucose sensor. Respective electrochemical impedance spectroscopy (EIS) procedures may be performed for each of the WEs to obtain values of membrane resistance (Rmem) for each WE. A noise value and a calibration factor (CF) value may be calculated for each WE, and respective fusion weights may be calculated for Rmem, noise, and CF for each WE. An overall fusion weight may then be calculated based on the WE's Rmem fusion weight, noise fusion weight, and CF fusion weight, such that a single, optimal, fused sensor glucose value may be calculated based on the respective overall fusion weight and sensor glucose value of each of the plurality of redundant working electrodes.
    Type: Application
    Filed: January 10, 2022
    Publication date: April 28, 2022
    Inventors: Andrea Varsavsky, Yunfeng Lu, Jay Mung
  • Publication number: 20220095964
    Abstract: A method for optional external calibration of a calibration-free glucose sensor uses values of measured working electrode current (Isig) and EIS data to calculate a final sensor glucose (SG) value. Counter electrode voltage (Vcntr) may also be used as an input. Raw Isig and Vcntr values may be preprocessed, and low-pass filtering, averaging, and/or feature generation may be applied. SG values may be generated using one or more models for predicting SG calculations. When an external blood glucose (BG) value is available, the BG value may also be used in calculating the SG values. A SG variance estimate may be calculated for each predicted SG value and modulated, with the modulated SG values then fused to generate a fused SG. A Kalman filter, as well as error detection logic, may be applied to the fused SG value to obtain a final SG, which is then displayed to the user.
    Type: Application
    Filed: December 9, 2021
    Publication date: March 31, 2022
    Inventors: Jeffrey Nishida, Andrea Varsavsky, Taly G. Engel, Keith Nogueira, Andy Y. Tsai, Peter Ajemba
  • Patent number: 11253176
    Abstract: A single, optimal, fused sensor glucose value may be calculated based on respective sensor glucose values of a plurality of redundant working electrodes (WEs) of a glucose sensor. Respective electrochemical impedance spectroscopy (EIS) procedures may be performed for each of the WEs to obtain values of membrane resistance (Rmem) for each WE. A noise value and a calibration factor (CF) value may be calculated for each WE, and respective fusion weights may be calculated for Rmem, noise, and CF for each WE. An overall fusion weight may then be calculated based on the WE's Rmem fusion weight, noise fusion weight, and CF fusion weight, such that a single, optimal, fused sensor glucose value may be calculated based on the respective overall fusion weight and sensor glucose value of each of the plurality of redundant working electrodes.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: February 22, 2022
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Andrea Varsavsky, Yunfeng Lu, Jay Mung
  • Patent number: 11213230
    Abstract: A method for optional external calibration of a calibration-free glucose sensor uses values of measured working electrode current (Isig) and EIS data to calculate a final sensor glucose (SG) value. Counter electrode voltage (Vcntr) may also be used as an input. Raw Isig and Vcntr values may be preprocessed, and low-pass filtering, averaging, and/or feature generation may be applied. SG values may be generated using one or more models for predicting SG calculations. When an external blood glucose (BG) value is available, the BG value may also be used in calculating the SG values. A SG variance estimate may be calculated for each predicted SG value and modulated, with the modulated SG values then fused to generate a fused SG. A Kalman filter, as well as error detection logic, may be applied to the fused SG value to obtain a final SG, which is then displayed to the user.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: January 4, 2022
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Jeffrey Nishida, Andrea Varsavsky, Taly G. Engel, Keith Nogueira, Andy Y. Tsai, Peter Ajemba
  • Publication number: 20210386335
    Abstract: Methods and systems for sensor calibration and sensor glucose (SG) fusion are used advantageously to improve the accuracy and reliability of orthogonally redundant glucose sensor devices, which may include optical and electrochemical glucose sensors. Calibration for both sensors may be achieved via fixed-offset and/or dynamic regression methodologies, depending, e.g., on sensor stability and Isig-Ratio pair correlation. For SG fusion, respective integrity checks may be performed for SG values from the optical and electrochemical sensors, and the SG values calibrated if the integrity checks are passed. Integrity checks may include checking for sensitivity loss, noise, and drift. If the integrity checks are failed, in-line sensor mapping between the electrochemical and optical sensors may be performed prior to calibration.
    Type: Application
    Filed: August 27, 2021
    Publication date: December 16, 2021
    Inventors: Andrea Varsavsky, Xiaolong Li, Mike C. Liu, Yuxiang Zhong, Ning Yang
  • Publication number: 20210275742
    Abstract: A method of automatically initializing an analyte sensor for a user is disclosed here. A first analyte sensor is operated in a first measurement mode to generate first sensor signals indicative of an analyte level of the user. A second analyte sensor is deployed to measure the analyte level of the user, and is operated in an initialization mode, concurrently with operation of the first analyte sensor in the first measurement mode, to receive sensor configuration data generated by the first analyte sensor. During operation of the second analyte sensor in the initialization mode, the second analyte sensor is calibrated with at least some of the received sensor configuration data. After the calibrating, operation of the second analyte sensor is transitioned from the initialization mode to a second measurement mode during which the second analyte sensor generates second sensor signals indicative of the analyte level of the user.
    Type: Application
    Filed: March 6, 2020
    Publication date: September 9, 2021
    Inventors: Erik Montero, David C. Antonio, Eric Allan Larson, Meng Dai Yu, Samuel Finney, Hans K. Wenstad, David M. Aguirre, Andrew P. Lynch, Andrea Varsavsky, Ali Dianaty
  • Patent number: 11103164
    Abstract: Methods and systems for sensor calibration and sensor glucose (SG) fusion are used advantageously to improve the accuracy and reliability of orthogonally redundant glucose sensor devices, which may include optical and electrochemical glucose sensors. Calibration for both sensors may be achieved via fixed-offset and/or dynamic regression methodologies, depending, e.g., on sensor stability and Isig-Ratio pair correlation. For SG fusion, respective integrity checks may be performed for SG values from the optical and electrochemical sensors, and the SG values calibrated if the integrity checks are passed. Integrity checks may include checking for sensitivity loss, noise, and drift. If the integrity checks are failed, in-line sensor mapping between the electrochemical and optical sensors may be performed prior to calibration.
    Type: Grant
    Filed: February 4, 2019
    Date of Patent: August 31, 2021
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Andrea Varsavsky, Xiaolong Li, Mike C. Liu, Yuxiang Zhong, Ning Yang
  • Publication number: 20210174960
    Abstract: Medical devices and related systems and methods are provided.
    Type: Application
    Filed: April 14, 2020
    Publication date: June 10, 2021
    Inventors: Elaine Gee, Peter Ajemba, Bahman Engheta, Jeffrey Nishida, Andrea Varsavsky, Keith Nogueira
  • Publication number: 20210174949
    Abstract: Medical devices and related systems and methods are provided. A method of estimating a physiological condition involves determining a translation model based at least in part on relationships between first measurement data corresponding to instances of a first sensing arrangement and second measurement data corresponding to instances of a second sensing arrangement, obtaining third measurement data associated with the second sensing arrangement, determining simulated measurement data for the first sensing arrangement by applying the translation model to the third measurement data, and determining an estimation model for a physiological condition using the simulated measurement data, wherein the estimation model is applied to subsequent measurement output provided by an instance of the first sensing arrangement to obtain an estimated value for the physiological condition.
    Type: Application
    Filed: April 14, 2020
    Publication date: June 10, 2021
    Inventors: Elaine Gee, Peter Ajemba, Bahman Engheta, Jeffrey Nishida, Andrea Varsavsky, Keith Nogueira
  • Publication number: 20210170103
    Abstract: Medical devices and related systems and methods are provided. A method of estimating a physiological condition using a first sensing arrangement involves obtaining a sensor translation model associated with a relationship between the first sensing arrangement and a second sensing arrangement, wherein the second sensing arrangement is different from the first sensing arrangement, obtaining one or more measurements from a sensing element coupled to the processing system of the first sensing arrangement, determining simulated measurement data for the second sensing arrangement by applying the sensor translation model to the one or more measurements from the sensing element of the first sensing arrangement, and determining an estimated value for the physiological condition by applying an estimation model associated with the second sensing arrangement to the simulated measurement data.
    Type: Application
    Filed: April 14, 2020
    Publication date: June 10, 2021
    Inventors: Elaine Gee, Peter Ajemba, Bahman Engheta, Jeffrey Nishida, Andrea Varsavsky, Keith Nogueira
  • Publication number: 20210161439
    Abstract: Methods and systems for sensor calibration and sensor glucose (SG) fusion are used advantageously to improve the accuracy and reliability of orthogonally redundant glucose sensor devices, which may include optical and electrochemical glucose sensors. Calibration for both sensors may be achieved via fixed-offset and/or dynamic regression methodologies, depending, e.g., on sensor stability and Isig-Ratio pair correlation. For SG fusion, respective integrity checks may be performed for SG values from the optical and electrochemical sensors, and the SG values calibrated if the integrity checks are passed. Integrity checks may include checking for sensitivity loss, noise, and drift. If the integrity checks are failed, in-line sensor mapping between the electrochemical and optical sensors may be performed prior to calibration.
    Type: Application
    Filed: February 12, 2021
    Publication date: June 3, 2021
    Inventors: ANDREA VARSAVSKY, XIAOLONG LI, MIKE C. LIU, YUXIANG ZHONG, NING YANG
  • Publication number: 20210113111
    Abstract: Electrochemical Impedance Spectroscopy (EIS) is used in conjunction with continuous glucose monitors and continuous glucose monitoring (CGM) to enable in-vivo sensor calibration, gross (sensor) failure analysis, and intelligent sensor diagnostics and fault detection. An equivalent circuit model is defined, and circuit elements are used to characterize sensor behavior.
    Type: Application
    Filed: December 8, 2020
    Publication date: April 22, 2021
    Inventors: ANDREA VARSAVSKY, FEI YU, NING YANG
  • Patent number: 10952651
    Abstract: Methods and systems for sensor calibration and sensor glucose (SG) fusion are used advantageously to improve the accuracy and reliability of orthogonally redundant glucose sensor devices, which may include optical and electrochemical glucose sensors. Calibration for both sensors may be achieved via fixed-offset and/or dynamic regression methodologies, depending, e.g., on sensor stability and Isig-Ratio pair correlation. For SG fusion, respective integrity checks may be performed for SG values from the optical and electrochemical sensors, and the SG values calibrated if the integrity checks are passed. Integrity checks may include checking for sensitivity loss, noise, and drift. If the integrity checks are failed, in-line sensor mapping between the electrochemical and optical sensors may be performed prior to calibration.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: March 23, 2021
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Andrea Varsavsky, Xiaolong Li, Mike C. Liu, Yuxiang Zhong, Ning Yang
  • Publication number: 20210076993
    Abstract: Embodiments of the invention provide compositions useful in implantable devices such as analyte sensors as well as methods for making and using such compositions and devices. In typical embodiments of the invention, the device is a glucose sensor comprising a polymeric composition that includes amounts of one or more immunosuppressant agents so as to provide such membranes with improved material properties such as enhanced biocompatibility.
    Type: Application
    Filed: September 18, 2020
    Publication date: March 18, 2021
    Applicant: Medtronic MiniMed, Inc.
    Inventors: Inthirai Somasuntharam, Jake Matteson, Matthew Jolly, Quyen Ong, Akhil Srinivasan, Poonam Gulati, Andrea Varsavsky, Sana Suhail